Work

A Phase 1/2 Study of Autologous Neuroblastoma Tumor Cells Genetically Modified to Secrete IL-2 in Patients With High-risk Neuroblastoma

Year: 2008

Type: article

Study design: Clinical Trial

Source: Journal of Immunotherapy

DOI: 10.1097/cji.0b013e3181869893

Authors: Heidi V. Russell, Douglas Strother, Zhuyong Mei, Donna Rill, Edwina Popek, Ettore Biagi, Eric Yvon, Malcolm Brenner, Raphael Rousseau

Institutions: University of Calgary, Alberta Children's Hospital, Baylor College of Medicine, University of Milano-Bicocca, Lyon 1 Université, Centre Léon Bérard

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute, National Center for Research Resources

Awards: ACTIVITY OF LYMPHOTACTIN IN CHILDHOOD MALIGNANCY, General Clinical Research Center, G71706220, G816013388

OpenAlex ID: W2075428230

FWCI: 2.16

Cites: 28

Cited by: 36

Related to: 10